Abstract:Background
Prostate cancer is often a slowly progressive indolent disease. Unnecessary treatments from overdiagnosis are a significant concern, particularly low-grade disease. Active surveillance has being considered as a risk management strategy to avoid potential side effects by unnecessary radical treatment. In 2016, American Society of Clinical Oncology (ASCO) endorsed the Cancer Care Ontario (CCO) Clinical Practice Guideline on active surveillance for the management of localized prostate c… Show more
“…developed a DL model to determine whether patients should choose AS or RP based on the proportions of GP 4 and 5, achieving an AUC of 0.84 for identifying indolent tumors suitable for AS. 92 However, accurately identifying AS patients at higher risk of disease progression remains challenging. Chandramouli et al.…”
Section: Empowering Pathologists: Ai As a Collaborative Toolmentioning
“…developed a DL model to determine whether patients should choose AS or RP based on the proportions of GP 4 and 5, achieving an AUC of 0.84 for identifying indolent tumors suitable for AS. 92 However, accurately identifying AS patients at higher risk of disease progression remains challenging. Chandramouli et al.…”
Section: Empowering Pathologists: Ai As a Collaborative Toolmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.